Prostamax

Prostamax is a peptide bioregulator preparation derived from bovine prostate tissue, developed within the Russian peptide bioregulator research program pioneered by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Bioregulators in this system are short tissue-specific peptides (typically 2–4 amino acids) that are hypothesized to regulate gene expression in a tissue-specific manner through epigenetic mechanisms.

The bioregulatory theory proposes that each tissue contains regulatory peptides that normalize cellular function — reducing overactive cells and stimulating underactive ones. For prostate-derived bioregulators, research has examined effects on prostate cell proliferation, secretory function, and response to inflammatory signals. Animal studies have documented tissue-specific effects consistent with this model, with results reported in prostate health models.

Prostamax is used in research examining prostate cell biology, benign prostatic hyperplasia models, and the general biology of peptide bioregulators as a class. The bioregulator literature is primarily Russian, and independent replication of many findings remains limited — a consideration for researchers reviewing the evidence base.